Mark H. Lee
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
A Novel Germline DDX41 Truncating Variant c.24del (p.Lys9Serfs*71): Deleterious Transfer During Related Allogeneic Hematopoietic Stem Cell Transplantation.
Journal: International journal of laboratory hematology
Published: December 17, 2024
Recent Updates of PET in Lymphoma: FDG and Beyond.
Journal: Biomedicines
Published: September 07, 2024
Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation.
Journal: Frontiers in oncology
Published: May 29, 2023
Clinical Impact of Recipient-Derived Isoagglutinin Levels in ABO-Incompatible Hematopoietic Stem Cell Transplantation.
Journal: Journal of clinical medicine
Published: November 22, 2022
Radioimmunotherapy with 131 I-rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma.
Journal: Asia-Pacific journal of clinical oncology
Published: November 02, 2022
FDG PET/CT Maximum Tumor Dissemination to Predict Recurrence in Patients with Diffuse Large B-Cell Lymphoma.
Journal: Nuclear medicine and molecular imaging
Published: June 12, 2022
Incidence and risk factors of opportunistic infections after autologous stem cell transplantation: a nationwide, population-based cohort study in Korea.
Journal: Scientific reports
Published: March 20, 2022
Busulfan, Melphalan, and Etoposide (BuME) Showed an Equivalent Effect to Busulfan, Cyclophosphamide, and Etoposide (BuCE) as Conditioning Therapy for Autologous Stem Cell Transplantation in Patients with Relapsed or High-Risk Non-Hodgkin's Lymphoma: A Multicenter Randomized Phase II Study bythe Consortium for Improving Survival of Lymphoma (CISL).
Journal: Cancer research and treatment
Published: January 03, 2022
Cutaneous T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in Asia.
Journal: International journal of hematology
Published: March 17, 2021
Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia.
Journal: The Lancet regional health. Western Pacific
Published: December 16, 2020
Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone.
Journal: International journal of hematology
Published: June 30, 2020
Treatment with intravenous busulfan, melphalan, and etoposide followed by autologous stem cell transplantation in patients with non-Hodgkin's lymphoma: a multicenter study from the consortium for improving survival of lymphoma.
Journal: Transplant international : official journal of the European Society for Organ Transplantation
Published: September 06, 2019
Last Updated: 09/26/2026